Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Summit Therapeu ADR
(NQ:
SMMT
)
3.535
-0.035 (-0.98%)
Streaming Delayed Price
Updated: 10:05 AM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
44,983
Open
3.610
Bid (Size)
3.530 (5)
Ask (Size)
3.540 (4)
Prev. Close
3.570
Today's Range
3.525 - 3.630
52wk Range
1.300 - 5.220
Shares Outstanding
97,381,774
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
April 11, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
April 10, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Performance
YTD
+33.90%
+33.90%
1 Month
-14.09%
-14.09%
3 Month
+5.52%
+5.52%
6 Month
+87.04%
+87.04%
1 Year
+123.73%
+123.73%
More News
Read More
Why Summit Therapeutics Stock Crushed the Market This Week
March 29, 2024
Via
The Motley Fool
Akeso Marks Profit Milestone With Swift Rights Issue
March 28, 2024
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 28, 2024
Via
Benzinga
Analysts Eye Summit Therapeutics' Ivonescimab As Potential Challenger To Merck's Keytruda in Lung Cancer Treatment
March 26, 2024
Via
Benzinga
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
March 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 18, 2024
Via
Benzinga
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024
March 14, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
Via
Benzinga
Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
March 05, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
February 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
February 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 20, 2024
Via
Benzinga
Dow Dips Over 100 Points; US Leading Economic Index Falls In January
February 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023
February 20, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024
February 14, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Present at Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For February 20, 2024
February 20, 2024
Via
Benzinga
Chart Of The Day: Summit Therapeutics Begins To Soar
January 25, 2024
Via
Talk Markets
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 24, 2024
Via
Benzinga
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
January 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.